Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

GlaxoSmithKline to acquire Corixa Corporation

GlaxoSmithKline has announced the execution of a definitive agreement pursuant to which GSK will acquire Corixa Corporation, a developer of innovative products that regulate immunity, based in Seattle, WA (USA).

2 May 2005

Aging population correlates with a switch from acute infectious diseases to chronic diseases as the major cause of morbidity and mortality

Some diseases like ulcers and certain types of cancer, once thought to be primarily related to lifestyle factors, are now known to be caused by microorganisms, and many more syndromes, including some psychiatric conditions, may have a connection to infection, according to a report released today by the American Academy of Microbiology.

22 Apr 2005

Rates of cervical cancer could jump fourfold to a million a year by 2050

Deaths from cervical cancer could jump fourfold to a million a year by 2050, mainly in developing countries. This could be prevented by soon-to-be-approved vaccines against the virus that causes most cases of cervical cancer- but there are signs that opposition to the vaccines might lead to many preventable deaths. The trouble is that the human papilloma virus (HPV) is sexually transmitted.

13 Apr 2005

Canadian cancer crisis due to aging population

According to a report by the Canadian Cancer Society, Canada's aging baby-boomers and the growing population are creating a cancer crisis, and while survival rates for many major cancers continue to improve, the Society projects that there will be 149,000 new cases of cancer diagnosed this year and 69,500 people will die of the disease, 3,500 more new cases and 1,200 deaths over last year.

12 Apr 2005

Vaccine against the virus that causes cervical cancer and genital warts shows promise

A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.

12 Apr 2005

UAB reaction to Lancet study on human papilloma virus (HPV)

The prominent British medical journal Lancet published results of a clinical trial on a vaccine for human papilloma virus (HPV) The virus is a leading cause of cervical cancer and genital warts.

10 Apr 2005

Race to market cancer vaccine

In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.

7 Apr 2005

Vaccine against cervical cancer and genital warts looks hopeful

More than two thirds of sexually active women will become infected with human papillomavirus (HPV) during their lifetime. HPV causes around 470 000 cases of cervical cancer each year and even though most cases of cervical cancer occur in the developing world, where cervical screening programmes are in the main non-existent, in Europe and the US 35000 women die from the disease every year.

6 Apr 2005

Certain combinations of genes increase the risk of developing cervical cancer

Certain combinations of genes that encode receptors on innate immune cells increase the risk of developing cervical cancer, according to a study by Mary Carrington and colleagues in the April 4 issue of The Journal of Experimental Medicine.

4 Apr 2005

Researchers show role of Epstein-Barr virus in cancer

Researchers at the University of Toronto have mapped the molecular details that show how a viral protein coded in the Epstein-Barr virus immortalizes cells and causes them to continuously grow, thereby predisposing people to certain types of cancer.

3 Apr 2005

Late developers more at risk from sexually transmitted disease

Researchers at the Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, Manchester, UK, have found that late developers may run a higher risk of infection than sexually mature younger teens.

From The University of Manchester 3 Apr 2005

Risky surgery not always necessary to treat cervical disease

Revolutionary advancements in the treatment options for diseases associated with human papillomavirus (HPV) now include nonsurgical options such as chemoprevention and vaccines. A review of these methods is published in the latest issue of the International Journal of Gynecological Cancer.

28 Mar 2005

Risky surgery not always necessary to treat cervical disease

23 Mar 2005

Women’s attitudes toward a potential cervical cancer vaccine

In a study of 200 women, a group of physicians has found that a vast majority of women would be willing to take a cervical cancer vaccine themselves and would allow it to be administered to their children.

23 Mar 2005

Women with HIV need cervical cancer check every 3 years

Tiffany G. Harris, Ph.D., from Albert Einstein College of Medicine, Bronx, N.Y., and colleagues in a study to see if a single, initial human papillomavirus (HPV) test result could be used to decide how often an HIV-seropositive woman with normal cervical cytology should be screened for cervical cancer, looked at the incidence of abnormal cervical lesions among HIV-seropositive and HIV-seronegative women enrolled in the Women’s Interagency HIV Study (WIHS).

22 Mar 2005

Risky surgery not always necessary to treat cervical disease

16 Mar 2005

Antiretroviral therapy may prevent some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

15 Mar 2005